Likewise, the decrease of CIAPIN1 expression in colorectal cancer, pancreatic cancer, and non-small cell lung carcinoma has been significantly associated with the clinical outcome of cancer patients; patients with weak or negative CIAPIN1 expression are always associated with longer survival duration [25,26,27]. The gene discussed is CIAPIN1; the disease is non-small cell lung carcinoma.